Originalartikel | erschienen - Druck | peer reviewed | Open Access
Randomized, placebo-controlled study on efficacy, safety and tolerability of drug-induced defibrinogenation for sudden sensorineural hearing loss: the lessons learned.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
2023 / März
;
280(9):
4009 - 4018
Bibliometrische Indikatoren
Impact Factor = 1,9
DOI = 10.1007/s00405-023-07896-z
PubMed-ID = 36881166
Autoren
Weiss B*, Spiegel J, Becker S, Strieth S, Olzowy B, Bertlich M, Fořt T, Mejzlik J, Lenarz T, Ihler F1, Canis M
Beteiligte Einrichtungen
Abstract
Disturbance of cochlear microcirculation is discussed as final common pathway of various inner ear diseases. Hyperfibrinogenemia causing increased plasma viscosity is a possible factor for a critical reduction of cochlear blood flow that might lead to sudden sensorineural hearing loss (SSHL). The aim was to determine the efficacy and safety of drug-induced defibrinogenation by ancrod for SSHL.
Veröffentlicht in
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
Jahr | 2023 |
Monat/Hj. | März |
Impact Factor (2023) | 1,9 |
Volume | 280 |
Issue | 9 |
Seiten | 4009 - 4018 |
Open Access | ja |
Peer reviewed | ja |
Artikelart | Originalartikel |
Artikelstatus | erschienen - Druck |
DOI | 10.1007/s00405-023-07896-z |
PubMed-ID | 36881166 |
Allgemeine Daten zur Fachzeitschrift
Kurzbezeichnung: EUR ARCH OTO-RHINO-L
ISSN: 0937-4477
eISSN: 1434-4726
Land: GERMANY (FED REP GER)
Sprache: English
Kategorie(n):
Impact Factor Entwicklung
ISSN: 0937-4477
eISSN: 1434-4726
Land: GERMANY (FED REP GER)
Sprache: English
Kategorie(n):
- OTORHINOLARYNGOLOGY
Impact Factor Entwicklung
Jahr | Impact Factor |
---|---|
2008 | 0,843 |
2009 | 1,167 |
2010 | 1,214 |
2011 | 1,287 |
2012 | 1,458 |
2013 | 1,608 |
2014 | 1,545 |
2015 | 1,627 |
2016 | 1,66 |
2017 | 1,546 |
2018 | 1,75 |
2019 | 1,809 |
2020 | 2,503 |
2021 | 3,236 |
2022 | 2,6 |
2023 | 1,9 |
2024 | 2,2 |
FAQs | Impressum | Datenschutz